2008
DOI: 10.1016/j.jbspin.2008.01.026
|View full text |Cite
|
Sign up to set email alerts
|

Serum levels of MMP-3 and cathepsin K in patients with ankylosing spondylitis: Effect of TNFα antagonist therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
19
1
2

Year Published

2009
2009
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 43 publications
(25 citation statements)
references
References 14 publications
3
19
1
2
Order By: Relevance
“…In agreement with our study, De Seny et al (2008) revealed that MMP-3 serum level apparently increased in patients with AS when compared to healthy subjects and the serum levels of MMP-3 combined with C-reactive protein (CRP) can also reflect the disease activity of AS. In contrast, Wendling et al (2008) indicated that serum MMP-3 level could not be a serum marker for the progression of AS.…”
Section: Discussionmentioning
confidence: 90%
See 2 more Smart Citations
“…In agreement with our study, De Seny et al (2008) revealed that MMP-3 serum level apparently increased in patients with AS when compared to healthy subjects and the serum levels of MMP-3 combined with C-reactive protein (CRP) can also reflect the disease activity of AS. In contrast, Wendling et al (2008) indicated that serum MMP-3 level could not be a serum marker for the progression of AS.…”
Section: Discussionmentioning
confidence: 90%
“…Two additional studies were removed after further assessment. Finally, 13 case-control studies were analyzed in the current meta-analysis (Yang et al, 2004b;Chen et al, 2006;de Seny et al, 2008;Lin et al, 2008;Sun and Yang, 2008;Wendling et al, 2008;Wang et al, 2010;Shen et al, 2011;Ma and Yang, 2012;Soliman et al, 2012;Dhir et al, 2013;Sha and Lei, 2013;Hou et al, 2014).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, certain MMPs are regulated by glucocorticoids via interference with the binding of the transcription factor activator protein-1, the major enhancer factor of the collagenase promoter (Jonat et al, 1990). Infliximab and other TNF-␣ antagonists can also act on the ECM by stimulating MMP activity and, therefore, ECM degradation (Wendling et al, 2008;Di Sabatino et al, 2009). Nonsteroidal anti-inflammatory drugs, which primarily inhibit cyclooxygenase enzymes and thereby prevent the synthesis of prostanoids, are able to ameliorate fibrotic processes via influencing TGF-␤ synthesis .…”
Section: Targeting Extracellular Matrix Molecules In Pharmacotherapy 207mentioning
confidence: 99%
“…Уровень катепсина К по-вышен в мононуклеарных и фибробластоподобных клет-ках больных АС [63], в то время как сывороточная концен-трация данного маркера не отличатся от таковой у здоро-вых лиц [64].…”
Section: лабораторные маркеры ремоделирования костной тканиunclassified